Combination of a dipeptidyl peptidase-4 inhibitor and an...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/00 (2006.01)

Patent

CA 2625646

The present invention relates to pharmaceutical compositions comprising a combination of a particular dipeptidyl peptidase-4 (DPP-4) inhibitor and an anti-hypertensive agent selected from the group consisting of an angiotensin II receptor antagonist and an angiotensin converting enzyme inhibitor, kits containing such combinations and methods of using such compositions for the treatment of diabetes, diabetes-related disorders, hypertension, and hypertension-related disorders.

La présente invention concerne des compositions pharmaceutiques comprenant une combinaison d'un inhibiteur de dipeptidyl peptidase-4 (DPP-4) particulier et d'un agent anti-hypertenseur sélectionné dans le groupe constitué par un antagoniste du récepteur de l'angiotensine II et un inhibiteur de l'enzyme de conversion de l'angiotensine, des nécessaires contenant lesdites combinaisons et des méthodes d'utilisation desdites compositions pour le traitement du diabète, de troubles liés au diabète, de l'hypertension et de troubles liés à l'hypertension.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination of a dipeptidyl peptidase-4 inhibitor and an... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination of a dipeptidyl peptidase-4 inhibitor and an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of a dipeptidyl peptidase-4 inhibitor and an... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1354292

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.